MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-28-0007101
Innogen Lifesciences Private Limited
Innogen Lifesciences Private Limited - chemicals in Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.05 Lakh
▼ 84% YoY
Net loss · FY 2025
₹10.03 Lakh
Net margin -247.6%
EBITDA · FY 2025
-₹9.35 Lakh
EBITDA margin -230.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Employees · EPFO
5
Provident fund records
Directors on board
2
As per MCA filings
About Innogen Lifesciences Private Limited
Data last updated:
Innogen Lifesciences Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 19 January 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24233UP2012PTC048463. Its GSTIN is 09AACCI8582J1Z0 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aditya Chaudhary and Jagdeep Singh Chaudhary.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 106 Sector – 88, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.05 Lakh, a decline of 84% compared to the previous year. For the same year it recorded a net loss of ₹10.03 Lakh (net margin -247.6%) and EBITDA of -₹9.35 Lakh (EBITDA margin -230.9%). Revenue has declined at a compounded annual rate (CAGR) of 55% over three years.
The company has about 5 employees on its provident fund (EPFO) records.
Innogen Lifesciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0007101). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233UP2012PTC048463
Registration Number 048463
Incorporation Date 19 January 2012
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-28-0007101
Recognitions & Rankings of Innogen Lifesciences
Contact details
Innogen Lifesciences Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 106 Sector – 88, Noida, Uttar Pradesh, India – 201301
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Innogen Lifesciences Private Limited, buy the company report.
Comprehensive company report
Innogen Lifesciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Innogen Lifesciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Innogen Lifesciences Private Limited, buy the company report.
Financials of Innogen Lifesciences Private Limited
FY 2025 filings availableInnogen Lifesciences Private Limited reported revenue of ₹4.05 Lakh (down 84% YoY) for FY 2025.
Revenue · FY 2025
₹4.05 Lakh ▼ 84%
Net loss · FY 2025
₹10.03 Lakh margin -247.6%
EBITDA · FY 2025
-₹9.35 Lakh margin -230.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 84%
3 years · compounded
▼ 55%
EBITDA CAGR growth
1 year
▲ 57%
3 years · compounded
▼ 15%
5 years · compounded
▼ 87%
Revenue has declined at a compounded annual rate (CAGR) of 55% over three years, including a 84% fall in the latest year. EBITDA rose 57% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9.35 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -230.9% | ||||
| Net Profit Margin | -247.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innogen Lifesciences Private Limited, buy the company report.
Board of directors of Innogen Lifesciences Private Limited
Innogen Lifesciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aditya Chaudhary | Director | 25 Jun 2019 | 7 Years 4 Months | Current |
| Jagdeep Singh Chaudhary | Director | 19 Jan 2012 | 14 Years 9 Months | Current |
Peer comparison
Innogen Lifesciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ayuva Lifesciences Private Limited | ₹4.1 Lakh (FY 2021) | -84.0% | Mandsaur, Madhya Pradesh, India | |||
| Hedonism Lifesciences Private Limited | ₹4.06 Lakh (FY 2024) | 7.0% | Lucknow, Uttar Pradesh, India | |||
| Innogen Lifesciences Private Limitedthis company | ₹4.05 Lakh (FY 2025) | -₹10.03 Lakh | -247.6% | -84.0% | 5 | Noida, Uttar Pradesh, India |
| Cma Genesis Remedies Private Limited | ₹3.98 Lakh (FY 2016) | -1.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Innogen Lifesciences Private Limited, buy the company report.
Auditor
Innogen Lifesciences Private Limited is audited by JALAJ PRASHAR & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JALAJ PRASHAR & CO. | FY 2017 | 013422C |
Shareholding
The shareholding of Innogen Lifesciences Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Innogen Lifesciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Innogen Lifesciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innogen Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Innogen Lifesciences Private Limited has a workforce of 5 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
5
Active EPFO establishments
1
Employee growth
-37.5%
GST
Innogen Lifesciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCI8582J1Z0 | Uttar Pradesh | Active | 20 Oct 2020 |
To see the full GST registrations and return filing status of Innogen Lifesciences Private Limited, buy the company report.
Recent activity
Innogen Lifesciences Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Snehdeep ceased to be Director on 27 Jun 2019.
AGM
Innogen Lifesciences Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Innogen Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Ceased
Snehdeep ceased to be Director.
Appointed
Aditya Chaudhary was appointed as Director.
Appointed
Jagdeep Singh Chaudhary was appointed as Director.
Incorporation
19 Jan 2012
Innogen Lifesciences Private Limited was registered on 19 Jan 2012 with Roc Uttar Pradesh Ii & aged 14 years 9 months as per MCA records.
Frequently asked questions
Innogen Lifesciences is an active private limited company based in Noida, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 19 January 2012 (14+ years old) and is registered under CIN U24233UP2012PTC048463.
Innogen Lifesciences has 2 current directors:
- Aditya Chaudhary - Director
- Jagdeep Singh Chaudhary - Director
The latest financial statements of Innogen Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Innogen Lifesciences is 09AACCI8582J1Z0, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Innogen Lifesciences is U24233UP2012PTC048463. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innogen Lifesciences was incorporated on 19 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Innogen Lifesciences by revenue are Ayuva Lifesciences Private Limited, Hedonism Lifesciences Private Limited, Cma Genesis Remedies Private Limited, all in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (wholesale trading).
Snehdeep ceased to be Director on 27 Jun 2019. Aditya Chaudhary was appointed as Director on 25 Jun 2019. Jagdeep Singh Chaudhary was appointed as Director on 19 Jan 2012.
Yes, Innogen Lifesciences is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0007101).
The registered office of Innogen Lifesciences is at B – 106 Sector – 88, Noida, Uttar Pradesh, India – 201301.
Innogen Lifesciences operates in the chemicals industry, in the manufacturing segment.